Cencora Other Healthcare Solutions — Revenue decreased by 4.0% to $1.05B in Q1 2026 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates successful expansion of service-based offerings and deeper integration into the pharmaceutical manufacturer value chain, while a decrease may suggest pricing pressure or reduced demand for specialized consulting and logistics support.
This metric represents the total revenue generated from specialized healthcare services, consulting, and logistics solut...
Peers in the pharmaceutical distribution space often report similar revenue under 'Services' or 'Specialty Solutions' segments, reflecting a strategic shift toward higher-margin, non-distribution revenue.
cor_segment_other_healthcare_solutions_revenue| Q4 '24 | Q1 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|
| Value | $959.70M | $924.79M | $1.09B | $1.05B |
| QoQ Change | — | -3.6% | +18.2% | -4.0% |
| YoY Change | — | — | +13.9% | +13.5% |